JP2009532494A5 - - Google Patents

Download PDF

Info

Publication number
JP2009532494A5
JP2009532494A5 JP2009504386A JP2009504386A JP2009532494A5 JP 2009532494 A5 JP2009532494 A5 JP 2009532494A5 JP 2009504386 A JP2009504386 A JP 2009504386A JP 2009504386 A JP2009504386 A JP 2009504386A JP 2009532494 A5 JP2009532494 A5 JP 2009532494A5
Authority
JP
Japan
Prior art keywords
discontinuation
renin inhibitor
medicament according
hypertension
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009504386A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009532494A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/065564 external-priority patent/WO2007118023A1/en
Publication of JP2009532494A publication Critical patent/JP2009532494A/ja
Publication of JP2009532494A5 publication Critical patent/JP2009532494A5/ja
Pending legal-status Critical Current

Links

JP2009504386A 2006-04-03 2007-03-30 高血圧処置のためのレニン阻害剤 Pending JP2009532494A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78884206P 2006-04-03 2006-04-03
PCT/US2007/065564 WO2007118023A1 (en) 2006-04-03 2007-03-30 Renin inhibitors for the treatment of hypertension

Publications (2)

Publication Number Publication Date
JP2009532494A JP2009532494A (ja) 2009-09-10
JP2009532494A5 true JP2009532494A5 (enExample) 2010-04-30

Family

ID=38420678

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009504386A Pending JP2009532494A (ja) 2006-04-03 2007-03-30 高血圧処置のためのレニン阻害剤

Country Status (20)

Country Link
US (1) US20090062395A1 (enExample)
EP (1) EP2004167A1 (enExample)
JP (1) JP2009532494A (enExample)
KR (1) KR20080108515A (enExample)
CN (1) CN101415413A (enExample)
AU (1) AU2007234917B2 (enExample)
BR (1) BRPI0710095A2 (enExample)
CA (1) CA2645260A1 (enExample)
CL (1) CL2007000912A1 (enExample)
IL (1) IL193905A0 (enExample)
MA (1) MA30387B1 (enExample)
MX (1) MX2008012729A (enExample)
NO (1) NO20084625L (enExample)
NZ (1) NZ571251A (enExample)
RU (1) RU2008143055A (enExample)
SG (1) SG170830A1 (enExample)
TN (1) TNSN08383A1 (enExample)
TW (1) TW200806283A (enExample)
WO (1) WO2007118023A1 (enExample)
ZA (1) ZA200807615B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009087116A1 (en) * 2008-01-11 2009-07-16 Novartis Ag Use of spp100 for the treatment of acute mi
CN102212012A (zh) * 2010-04-12 2011-10-12 上海源力生物技术有限公司 一种合成阿利克伦的中间体及其制备方法
EP2768971A1 (en) 2011-10-20 2014-08-27 Institut National de la Santé et de la Recherche Médicale (INSERM) Methods for the detection and the treatment of cardiac remodeling
AU2020259450A1 (en) * 2019-04-18 2021-11-18 EyePoint Pharmaceuticals, Inc. Methods of treating hypertension with activators of Tie-2

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5606078A (en) * 1994-04-18 1997-02-25 Ciba-Geigy Corporation 3,5-Disubstituted tetrahydrofuran-2-ones
US5659065A (en) * 1994-04-18 1997-08-19 Novartis Corporation Alpha-aminoalkanoic acids and reduction products
MY119161A (en) * 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
CA2490811A1 (en) * 2002-06-28 2004-01-08 Novartis Ag Use of organic compounds
US20040266743A1 (en) * 2003-05-09 2004-12-30 Pharmacia Corporation Combination of an aldosterone receptor antagonist and a renin inhibitor
US20050209141A1 (en) * 2003-10-17 2005-09-22 Silver Randi B Mast cell-derived renin
AR048431A1 (es) * 2004-03-17 2006-04-26 Novartis Ag Formulaciones galenicas de compuestos organicos
ES2310293T3 (es) * 2004-09-27 2009-01-01 Pantarhei Bioscience B.V. Tratamiento o prevencion de sangrados no programados en mujeres bajo medicacion que contiene progestogeno.

Similar Documents

Publication Publication Date Title
JP2023002662A5 (enExample)
JP2021063088A5 (enExample)
FI3661514T3 (fi) Mavakamteeni käytettäväksi hypertrofisen kardiomyopatian hoidossa
JP2011528713A5 (enExample)
JP2012525393A5 (enExample)
JP2010077141A5 (enExample)
JP2009102342A5 (enExample)
JP2013522303A5 (enExample)
CN1856339A (zh) 肺动脉高血压症治疗的伊洛前列素联合疗法
RU2013121788A (ru) Ингибиторы репликации вич
RU2009110452A (ru) Галеновые составы алискирена
JP2014516942A5 (enExample)
JP2006503850A5 (enExample)
NZ592615A (en) Method for treating or preventing thrombosis using 150 mg b.i.d. of dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
JP2009513713A5 (enExample)
JP2017514911A5 (enExample)
JP2016507500A5 (enExample)
JP2009532494A5 (enExample)
JP2013528649A5 (enExample)
JP2006511538A5 (enExample)
JP2001515041A5 (enExample)
RU2007119067A (ru) Средство для лечения синдрома раздраженного кишечника с преобладанием диареи
NZ592613A (en) Method for treating or preventing thrombosis using >150 mg to 300 mg b.i.d. of dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
EA200601286A1 (ru) Фармацевтические композиции, содержащие ингибитор протонового насоса и прокинетический агент
JP2019516726A5 (enExample)